Review Article
Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment, and Control Measures
Table 1
A comparison of current diagnostic options for COVID-19.
| Platform | Specimen/material | Type | Time | Sensitivity (%) | Specificity (%) | Cross-reactivity |
| NAAT | Nasopharyngeal swab; sputum; bronchoalveolar lavage fluid; blood | RT-PCR | 240 mins | 71–98 | 95 | No | CRISPR | 40 mins | 97 | 100 | No |
| Serological | Nasopharyngeal swab; blood | Antibody | 15–30 mins | 92–100 | 93–100 | Yes | Antigen | 15–30 mins | 66–92 | 100 | Yes |
| Imaging | Chest X-ray Chest CT-scan | Radiologist | 15–30 mins | 74.6 | 93.8 | NA | AI | <5 mins | 84.3 | 82.8 | NA |
|
|